Skip to content

Intervention

Partial reprogramming (OSK)

Works
721
Clinical trials
14
Total citations
75,393
Open access
651

Evidence brief

preview

Synthesis (preview — no live AI key for the active provider):

Across the retrieved literature, senescent-cell burden and chronic inflammation recur as central, interacting drivers, with intervention studies reporting functional gains in model organisms. Key works: [1][2][3][4][5].

Read the full brief →

Publication velocity

19992026

Clinical trials

Most-cited works